🔬 It detects various contaminants like proteins, plastic, glass, and silicon oil droplets effectively.
📊 This method improves data quality and reduces resource use.
🧪 Developed by researchers at CalTech and Amgen, it is promising for ensuring patient safety in biopharmaceuticals.
Introduction:
The article discusses a novel, non-destructive technique for analyzing subvisible particles within pharmaceutical products, developed by a collaborative team at the California Institute of Technology (Caltech) and Amgen. The presence of subvisible particles in injectable drugs poses significant safety risks to patients, thus necessitating efficient detection methods. The new approach aims to enhance data quality while minimizing resource demands for biopharmaceutical manufacturers.
- The new analytical technique allows for the direct detection of various subvisible particles, including those from protein, plastic, and metal, without destroying the sample.
- A custom housing design helps minimize optical distortions caused by the curvature of vials during analysis.
- The methodology employs Mie scattering theory to estimate the size and concentration of particles in real time.
- Tests demonstrate that the analyzer can accurately quantify particle concentration in vials containing suspensions of polystyrene beads.
- This approach provides advantages such as improved data quality and reduced resource burden, enabling applications in stress testing and stability monitoring of drugs.
Conclusion:
The advancements in non-destructive analysis of subvisible particles mark a significant improvement for the biopharmaceutical industry, addressing both safety concerns and data integrity for injectable solutions. As the technique continues to develop, its integration into routine quality control processes could facilitate safer drug products and enhance manufacturing efficiencies.
